advanced hcc
Showing 1 - 4 of 4
Advanced HCC, Other Solid Tumors Trial in Shanghai (KD6001, Tislelizumab, Bevacizumab)
Not yet recruiting
- Advanced HCC
- Other Solid Tumors
- KD6001
- +2 more
-
Shanghai, ChinaZhongshan Hospital
Jun 13, 2023
Advanced HCC Trial in Beijing (KN046 (PD-L1/CTLA4 BsAb), Ningetinib Tosylate(multi-target TKI))
Terminated
- Advanced HCC
- KN046 (PD-L1/CTLA4 BsAb)
- Ningetinib Tosylate(multi-target TKI)
-
Beijing, Beijing, ChinaChinese Pla General Hospital Chinese Pla Medical School
Oct 26, 2022
Advanced HCC Trial in Hannover (Cyclophosphamide)
Completed
- Advanced HCC
-
Hannover, GermanyMedizinische Hochschule Hannover
Feb 3, 2009